Literature DB >> 14579811

Rosuvastatin calcium.

Jeremy Quirk, Mark Thornton, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579811     DOI: 10.1038/nrd1205

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  7 in total

1.  Rosuvastatin, Perindopril and Ezetimibe loaded instant release buccal films: Development and in vitro characterization.

Authors:  Sobia Anwar; Muhammad Zaman; Maria Abdul Ghafoor Raja; Asif Mahmood; Muhammad Wahab Amjad
Journal:  J Appl Biomed       Date:  2020-10-27       Impact factor: 1.797

2.  Catalyst- and solvent-free approach to 2-arylated quinolines via [5 + 1] annulation of 2-methylquinolines with diynones.

Authors:  Hai-Yuan Zhao; Fu-Song Wu; Li Yang; Ying Liang; Xiao-Lin Cao; Heng-Shan Wang; Ying-Ming Pan
Journal:  RSC Adv       Date:  2018-01-25       Impact factor: 4.036

3.  Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.

Authors:  Jieon Lee; Su-Jin Rhee; SeungHwan Lee; Kyung-Sang Yu
Journal:  Drug Des Devel Ther       Date:  2018-04-06       Impact factor: 4.162

4.  Chiral Syn-1,3-diol Derivatives via a One-Pot Diastereoselective Carboxylation/ Bromocyclization of Homoallylic Alcohols.

Authors:  Guanxin Huang; Minjie Liu; Fangjun Xiong; Ge Meng; Yuan Tao; Yan Wu; Haihui Peng; Fener Chen
Journal:  iScience       Date:  2018-11-09

5.  NH3⋅H2O: The Simplest Nitrogen-Containing Ligand for Selective Aerobic Alcohol Oxidation to Aldehydes or Nitriles in Neat Water.

Authors:  Guofu Zhang; Danting Ma; Yiyong Zhao; Guihua Zhang; Guangyao Mei; Jinghui Lyu; Chengrong Ding; Shang Shan
Journal:  ChemistryOpen       Date:  2018-11-13       Impact factor: 2.911

6.  Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.

Authors:  Sungjae Lee; Seungwon Yang; Min Jung Chang
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

7.  Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of Rosuvastatin: An in vitro and in vivo evaluation.

Authors:  Hina Shoukat; Fahad Pervaiz; Mehran Khan; Sadia Rehman; Faizan Akram; Usman Abid; Sobia Noreen; Muhammad Nadeem; Rubina Qaiser; Rizwan Ahmad; Irshad Farooq
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.